Business Wire

StimGuard’s Chronic Tibial Nerve Stimulation for OAB Versus Medtronic InterStim® Sacral Nerve Stimulation Study Commencing in USA With FDA IDE Approval

POMPANO BEACH, Fla.--(BUSINESS WIRE)--StimGuard, a privately-held, pre-commercial medical device company, today announced it is commencing a head-to-head study for its Chronic Affarent Nerve ...
Fierce Healthcare

Study Shows Medtronic InterStim® Therapy Improves Bowel Control and Related Quality of Life Issues at Three Years

InterStim Therapy for Bowel Control Recently Approved by the U.S. FDA MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) announced today that newly published data from a multicenter, ...
Nasdaq

Medtronic Expands Leadership in Treating Bladder and Bowel Control Conditions with Two New FDA-Approved Products: InterStim™ Micro Neurostimulator and InterStim™ SureScan ...

World’s Smallest Rechargeable Bladder/Bowel Control System — InterStim Micro — Features Trusted MRI Technology for Full-Body 1.5 and 3 Tesla MRI Scans Only Medtronic Offers Patients Personalized ...
Becker's ASC

Study: InterStim Incontinence Therapy Still Effective After 3 Years

A new multicenter study shows use of Medtronic’s InterStim Therapy via sacral nerve stimulation reduced incontinent episodes and improved quality of life in most patients with chronic fecal ...
Healio

FDA approves expanded labeling for sacral neuromodulation systems with SureScan MRI leads

Please provide your email address to receive an email when new articles are posted on . The FDA approved expanded labeling for Medtronic’s InterStim II and InterStim Micro sacral neuromodulation ...
Zanesville Times Recorder

Genesis urogynecologist recognized by medical device company for treatment usage

ZANESVILLE – Dr. Mitesh Parekh, a urogynecologist with Genesis Urogynecology, has been recognized by Medtronic, a medical device company, for outstanding contribution in positively impacting the lives ...
Nasdaq

Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim™ SureScan™ MRI Leads

DUBLIN, Feb. 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration ...
BioWorld

FDA greenlights Interstim Micro and Surescan MRI leads for bladder and bowel control

Medtronic plc has won U.S. FDA approval of its Interstim Micro rechargeable sacral nerve stimulator and Interstim Surescan MRI leads for the treatment of urinary and bowel dysfunctions. The new ...
Becker's ASC

InterStim in the ASC Setting: 2 Surgeons Weigh In

InterStim Therapy is a sacral neuromodulation therapy from Medtronic. InterStim has been regularly used for urinary incontinence for more than a decade, but recently received additional approval as ...
Healthline

What Is Sacral Nerve Stimulation for an Overactive Bladder?

An overactive bladder is a condition that causes a frequent and urgent need to urinate. Some people with this condition experience urinary incontinence, or the involuntary leakage of urine. Sacral ...
Medscape

Overactive Bladder: Drug Therapy Versus Nerve Stimulation

Nat Clin Pract Urol. 2005;2(7):310-311. The InterStim® device has greatly increased the number of candidates for surgical therapy. This therapy involves an initial percutaneous nerve evaluation to ...